NFSG
MBOT icon

Newbridge Financial Services Group’s Microbot Medical MBOT Stock Holding History

Newbridge Financial Services Group’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1
Closed -$1 – 925
2024
Q2 		$1 Hold
1
– – ﹤0.01% 1082
2024
Q1 		$1 Hold
1
– – ﹤0.01% 1176
2023
Q4 		$2 Hold
1
– – ﹤0.01% 1117
2023
Q3 		$1 Hold
1
– – ﹤0.01% 1282
2023
Q2 		$3 Hold
1
– – ﹤0.01% 1345
2023
Q1 		$2 Hold
1
– – ﹤0.01% 1406
2022
Q4 		$3 Hold
1
– – ﹤0.01% 1438
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1436
2022
Q2 		$0 Buy
+1
New +$6 ﹤0.01% 1452

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $100M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TFS
Thoroughbred Financial Services Brentwood, Tennessee $1.67B AUM 37.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Newbridge Financial Services Group's MBOT Position: Q3 2024 in Review

Newbridge Financial Services Group sold out of Microbot Medical (MBOT) in Q3 2024, closing a stake of 1 share — an estimated $1 sold.

Newbridge Financial Services Group first reported a position in MBOT in Q2 2022 and held it in 9 quarters. The position peaked at $3 in Q2 2023. 25 funds tracked by Wall St. Rank hold MBOT as of Q3 2024.

  • Newbridge Financial Services Group reported no remaining Microbot Medical position as of Q3 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 1 Microbot Medical share in Q3 2024, an estimated $1.
  • Newbridge Financial Services Group first reported a position in Microbot Medical in Q2 2022 and held it in 9 quarters.
  • Newbridge Financial Services Group's Microbot Medical position peaked at $3 in Q2 2023.
  • 25 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2024.

Based on Newbridge Financial Services Group's 13F filing for Q3 2024, filed 12 Nov 2024.